- Novavax said on Monday it has started the Phase 1 clinical trial of a coronavirus vaccine candidate and has enrolled the trial’s first participants, with preliminary results slated for July.
- Adjuvants are mainly used to make vaccines induce a strong immune response, including through the greater production of antibodies, and provide longer-lasting protection against viral and bacterial infection.
- Novavax said, upon successful completion of Phase 1, the Phase 2 portion of the trial will be conducted in several countries, including the United States.
Source: Novavax starts clinical trial of its coronavirus vaccine candidate